Using anti-inflammatories and dextrose injections to treat knee osteoarthritis
Official title: The Effect of Non-steroidal Anti-inflammatory Drug (NSAID) Use on the Efficacy of Dextrose Prolotherapy in the Treatment of Knee Osteoarthritis: A Randomized Controlled Trial
Run by David Grant U.S. Air Force Medical Center · NCT06911359 · Data updated 2026-11-12
This study is testing whether combining anti-inflammatory medication with dextrose injections can help adults aged 45-75 with knee osteoarthritis feel less pain.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 45 Years to 75 Years |
| Sex | All |
| Enrollment | 68 (estimated) |
| Sponsor | David Grant U.S. Air Force Medical Center Federal |
| Locations | 1 site (Travis AFB, California) |
| Status | Recruiting |
| Started | March 31, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | November 24, 2025 |
| Trial ID | NCT06911359 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 45-75 with chronic knee osteoarthritis who are beneficiaries of the Department of Defense and meet specific clinical criteria.
✕Probably not a fit
Patients who have had knee replacement surgery or recent intra-articular injections may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the safety and effectiveness of combining non-steroidal anti-inflammatory drugs (NSAIDs) with dextrose prolotherapy (DPT) injections in adults suffering from knee osteoarthritis. Participants aged 45-75 will receive either ibuprofen or a placebo alongside DPT injections over a series of three treatments. The study is designed as a double-blinded, randomized, controlled trial to ensure unbiased results. The goal is to determine if NSAIDs can be safely used without compromising the efficacy of DPT in alleviating knee pain.
Why it matters
Potential benefit: If successful, this approach could provide a new, effective treatment option for patients with knee osteoarthritis, potentially improving their quality of life.
How similar studies have gone: Previous pilot studies have shown promising results for the combined use of NSAIDs and DPT, indicating potential for success in this larger trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Must be DoD Healthcare beneficiaries empaneled at DGMC * Adults aged 45-75 years with a clinical diagnosis of Knee OA (either unilateral or bilateral) based on clinical and radiographic criteria as defined by the American College of Rheumatology (Altman 1987) * Knee radiographs (within 2 years of start date) with Kellgren-Lawrence classification of 2-3 * Moderate to severe Knee pain for at least 3 months defined as a score of ≥4 using the NPRS (0-10) in response to the question "What is the average level of your left/ right knee pain in the past 3 months?" * English speaking * Not pregnant * Not breastfeeding * No allergy to dextrose, lidocaine, or sulfite Exclusion Criteria: * Previous knee replacement surgery * Previous meniscus repair/debridement surgery or chondral replacement surgery * Any intra-articular injection including steroid, prolotherapy or platelet rich plasms within the previous 3 months * Significant effusion as defined by a ballotable patella * Pregnancy or breastfeeding * Current/ongoing medical problems obtained from chart review contraindicating NSAID use to include chronic kidney disease stage II or higher, acute interstitial nephritis, coronary artery disease requiring percutaneous coronary intervention (PCI) or bypass surgery; Major Adverse Coronary Event (MACE), body mass index (BMI) ≥40, inflammatory arthropathy (gouty arthritis, psoriatic arthritis, or septic arthritis), history of GI bleed. * Non-English speaking * Allergy to dextrose, lidocaine, or sulfite
Where it's running
-
David Grant USAF Medical Center
Travis AFB, California, United States Recruiting
Study contacts
- Principal investigator: Alexander R Kim, MD — David Grant USAF Medical Center
- Study coordinator: Alexander R Kim, MD
- Email: Alexander.r.kim.mil@health.mil
- Phone: 707-423-3057
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Platelet-rich plasma added to hyaluronic acid for knee osteoarthritis
This study tests whether a single injection of hyaluronic acid plus autologous platelet-rich plasma helps reduce knee OA symptoms more than hyaluronic acid alone in adults with moderate knee OA.
-
Hyaluronic Acid Plus PRP Injection for Knee Osteoarthritis
This study tests whether a single HA injection combined with a patient’s own PRP is better at easing knee OA pain than HA alone.
-
Weekly NNC0487-0111 injections for weight loss and knee pain in adults with excess weight and knee osteoarthritis
This will try weekly NNC0487-0111 injections versus placebo to see if adults with excess body weight and knee osteoarthritis can lose weight and have less knee pain.
-
Altered Joint Mechanics and Biological Response in Osteoarthritic Knees
This study tests how braces or high tibial osteotomy (HTO) affect knee bone and cartilage in people with knee OA who are scheduled for corrective treatment.
-
Why walking causes different amounts of knee pain in people with osteoarthritis
This project will see if differences in the brain, joint imaging, movement, and sensory responses explain why adults 45–80 with knee osteoarthritis have different levels of walking pain.
-
Reducing knee pain with Genicular Artery Embolization
This study is testing if a new procedure called Genicular Artery Embolization can help people with knee osteoarthritis pain who haven't found relief from other treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.